BMEA Bull Call Spread Strategy
BMEA (Biomea Fusion, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Biomea Fusion, Inc., a clinical-stage diabetes and obesity medicines company, focuses on the discovery and development of oral drugs to treat patients with diabetes and obesity. It’s lead clinical program’s drug candidates are COVALENT-111 and COVALENT-112, which has completed Phase II clinical trials of icovamenib for the treatment of Type 1 and Type 2 diabetes; COVALENT-211, which is in Phase II clinical trial of icovamenib for treating insulin-deficient type 2 diabetes; and COVALENT-212, which is in Phase II clinical trial of icovamenib for the treatment of type 2 diabetes. The company is also developing BMF-650, which is in Phase I glucagon-like peptide-131 clinical trial for the treatment of obesity. The company was incorporated in 2017 and is headquartered in San Carlos, California.
BMEA (Biomea Fusion, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $95.4M, a beta of -0.30 versus the broader market, a 52-week range of 0.8719-2.99, average daily share volume of 1.3M, a public-listing history dating back to 2021, approximately 37 full-time employees. These structural characteristics shape how BMEA stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of -0.30 indicates BMEA has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a bull call spread on BMEA?
A bull call spread buys an at-the-money call and sells an out-of-the-money call at a higher strike for defined risk and defined reward bounded by the strike width.
BMEA snapshot
As of September 29, 2026, spot at $1.27, ATM IV 62.00%, IV rank 17.18%, expected move 17.77%. The bull call spread on BMEA below is built from the end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.
Why this bull call spread structure on BMEA specifically: BMEA IV at 62.00% is on the cheap side of its 1-year range, which favors premium-buying structures like a BMEA bull call spread, with a market-implied 1-standard-deviation move of approximately 17.77% (roughly $0.23 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated BMEA expiries trade a higher absolute premium for lower per-day decay. Position sizing on BMEA should anchor to the underlying notional of $1.27 per share and to the trader's directional view on BMEA stock.
BMEA bull call spread setup
The BMEA bull call spread below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With BMEA at $1.27 on that close, the first option leg uses a $1.27 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed BMEA chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 BMEA shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $1.27 | N/A |
| Sell 1 | Call | $1.33 | N/A |
BMEA bull call spread risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals strike width minus net debit times 100; max loss equals net debit times 100. Breakeven is long-call strike plus net debit.
BMEA bull call spread payoff curve
Modeled P&L at expiration across a range of underlying prices for the bull call spread on BMEA. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use bull call spread on BMEA
Bull call spreads on BMEA reduce the cost of a bullish BMEA stock position by selling a higher-strike call; suited to moderate-move theses where price reaches but does not vastly exceed the short strike.
BMEA thesis for this bull call spread
The market-implied 1-standard-deviation range for BMEA extends from approximately $1.04 on the downside to $1.50 on the upside. A BMEA bull call spread caps both the risk and the reward of a bullish position; relative to an outright long call on BMEA, the spread reduces the cost basis but limits the maximum profit to the strike width minus net debit. Current BMEA IV rank near 17.18% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on BMEA at 62.00%. As a Healthcare name, BMEA options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to BMEA-specific events.
BMEA bull call spread positions are structurally moderately bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. BMEA positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move BMEA alongside the broader basket even when BMEA-specific fundamentals are unchanged. Long-premium structures like a bull call spread on BMEA are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current BMEA chain quotes before placing a trade.
Frequently asked questions
- What is a bull call spread on BMEA?
- A bull call spread on BMEA is the bull call spread strategy applied to BMEA (stock). The strategy is structurally moderately bullish: A bull call spread buys an at-the-money call and sells an out-of-the-money call at a higher strike for defined risk and defined reward bounded by the strike width. With BMEA stock at $1.27 on the most recent close, the strikes shown on this page are snapped to the nearest listed BMEA chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are BMEA bull call spread max profit and max loss calculated?
- Max profit equals strike width minus net debit times 100; max loss equals net debit times 100. Breakeven is long-call strike plus net debit. For the BMEA bull call spread priced from the end-of-day chain at a 30-day expiry (ATM IV 62.00%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a BMEA bull call spread?
- The breakeven for the BMEA bull call spread priced on this page is no defined breakeven on the modeled curve at expiration, derived from the end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The BMEA market-implied 1-standard-deviation expected move in the same options snapshot is approximately 17.77%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a bull call spread on BMEA?
- Bull call spreads on BMEA reduce the cost of a bullish BMEA stock position by selling a higher-strike call; suited to moderate-move theses where price reaches but does not vastly exceed the short strike.
- How does current BMEA implied volatility affect this bull call spread?
- BMEA ATM IV is at 62.00% with IV rank near 17.18%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.